Search Orphan Drug Designations and Approvals
-
Generic Name: | Zandelisib |
---|---|
Date Designated: | 11/09/2021 |
Orphan Designation: | Treatment of follicular lymphoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 06/12/2023 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
MEI Pharma, Inc. 11455 El Camino Real Suite 250 San Diego, California 92130 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-